How much is ImmuneBridge worth in 2026?

ImmuneBridge has a current valuation of $11.0M based on their Seed Round round and secondary market data.

How much funding has ImmuneBridge raised?

ImmuneBridge has raised $17.6M in total funding across 0 funding rounds.

ImmuneBridge

Website

ImmuneBridge valuation and funding history | Last updated: April 1, 2025

Current Valuation

$11.0M

As of April 1, 2025

Total Funding Raised

$17.6M

Last Round

Seed Round

$5.6M

Last Funding

Apr 2025

Funding date

Capital Efficiency

0.62x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

ImmuneBridge is currently valued at $11.0M as of April 1, 2025. The company has raised a total of $17.6M in funding.

Capital Efficiency

With a capital efficiency ratio of 0.62x, ImmuneBridge has achieved a valuation that is 0.62 times the total capital raised.

Track ImmuneBridge Valuation Updates

Get notified when ImmuneBridge raises new funding or valuation changes

Explore More Data

Detailed analysis for ImmuneBridge

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock ImmuneBridge's valuation history, funding rounds, and growth metrics.

No credit card required

What is ImmuneBridge Worth in 2026?

ImmuneBridge is a leading private company in the technology sector. Track ImmuneBridge's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How ImmuneBridge Valuation is Determined

Private company valuations like ImmuneBridge's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.